Noemi Reguart路 @NReguart 路 X路路 1 day agoScore70
Body
馃毃 Awaited SAFFRON #ESMO26 OSI + savolitinib vs ChT EGFRm/MET+ NSCLC after 1L OSI. First positive targeted strategy post-progression!馃憦馃憦
馃敼 PFS: 7.6 vs 5.4 mo (HR 0.55)
馃敼 OS: 17.8 vs 12.9 mo (HR 0.68)
@NEJM New roads, challenges: biomarker testing IHC/NGS Tx, Liquid in focus!
70 views 路 3 likes 路 2 reposts 路 0 replies
Source: Noemi Reguart 路 x.com